This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignees: Mylan Laboratories Limited, Pfizer Corporation. Active years: 2015-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2015-2025
Title: Innovations and Contributions of Inventor Saidugari Swamy
Introduction
Saidugari Swamy is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compounds and methods. With a total of 2 patents, his work has garnered attention in the scientific community.
Latest Patents
Saidugari Swamy's latest patents include groundbreaking methods and intermediates for preparing hydrochloride salt of 5-[3-(3-hydroxyphenoxy)azetidin-1-yl]-5-methyl-2,2-diphenylhexanamide. This invention outlines a process that involves reacting 5-[3-(3-hydroxyphenoxy)azetidin-1-yl]-5-methyl-2,2-diphenylhexanenitrile benzoate with a reagent and hydrochloric acid to form the desired carboxamide compound. Additionally, he has developed a novel process for the preparation of the renin inhibitor Aliskiren and its derivatives, along with its pharmaceutically acceptable salts.
Career Highlights
Throughout his career, Saidugari Swamy has worked with prominent companies in the pharmaceutical industry, including Mylan Laboratories Limited and Pfizer Corporation. His experience in these organizations has contributed to his expertise in drug development and innovation.
Collaborations
Saidugari Swamy has collaborated with notable colleagues such as Vadali Lakshmana Rao and Dasari Srinivasa Rao. These partnerships have likely enhanced his research and development efforts, leading to successful patent applications.
Conclusion
Saidugari Swamy's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his role as a significant inventor. His work continues to impact the industry positively, paving the way for future advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile